High HIV incidence from non-primary partners and low PEP and PrEP use seen in PARTNER study
One in seven people offered PrEP in African study start it immediately
PrEP demand in England is rapidly accelerating – and most will want to join the trial
France’s next PrEP study aims to assess the wider impact of PrEP on the HIV epidemic
New NNRTI doravirine shows good efficacy in phase 3 study
NHS England announces major new PrEP trial for 2017
Realism needed about the benefits and risks of taking part in HIV cure studies
It’s all go for a new HIV vaccine efficacy trial this year
Maraviroc may work as PrEP in combination with another drug – but probably not by itself
